Consensus ESG Ratings
Member Sign In
ESG News For Arena Pharmaceuticals, Inc.
These sites contributed news to this page:
-
Corporate Social Responsibility Related News Releases and Story Ideas for Reporters, Bloggers and Media Outlets
Recap of CSR stories on Business Wire -
Arena Pharmaceuticals Earns "A" Rating from MSCI ESG, a Leading Rating Agency for Sustainable Investments
- Improvement by two score levels to "A" following the Company’s 2021 ESG Report launch underscores Arena's long-term commitment to ESG principles -
Corporate Social Responsibility Related News Releases and Story Ideas for Reporters, Bloggers and Media Outlets
Recap of CSR stories on Business Wire -
Arena Pharmaceuticals Earns Prime Status from ISS ESG, a Leading Rating Agency for Sustainable Investments
- ISS ESG Corporate Rating uses comprehensive research and data to allow institutional investors to identify Environmental, Social and Governance (ESG) risks and seize investment opportunities- Inaugural year of Prime status for Arena, following the Company’s 2021 ESG Report launch -
Corporate Social Responsibility Related News Releases and Story Ideas for Reporters, Bloggers and Media Outlets
Recap of CSR stories on Business Wire -
Arena Pharmaceuticals Releases Second Annual Environmental, Social and Governance (ESG) Report
- Company highlights dedication to patients, employees, the community, the environment, and shareholders through initiatives focused on responsibility and sustainability, diversity and inclusion, and patient commitment